{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T12:48:21Z","timestamp":1715518101091},"reference-count":62,"publisher":"Elsevier","isbn-type":[{"value":"9780128193785","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/b978-0-12-819378-5.00011-8","type":"book-chapter","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T23:18:10Z","timestamp":1613949490000},"page":"155-186","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacist-led interventions to promote cardiovascular health: A review of studies from Portugal"],"prefix":"10.1016","author":[{"given":"Filipa","family":"Alves da Costa","sequence":"first","affiliation":[]},{"given":"Ema","family":"Paulino","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0010","series-title":"Noncommunicable diseases global monitoring framework: indicator definitions and specifications","author":"World Health Organization","year":"2014"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0015","series-title":"Beating non\u2010communicable diseases in the community\u2014the contribution of pharmacists","author":"International Pharmaceutical Federation (FIP)","year":"2019"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0020","doi-asserted-by":"crossref","DOI":"10.1007\/s11096-010-9379-8","article-title":"Cardiovascular risk screening program in Australian community pharmacies","volume":"32","author":"Peterson","year":"2010","journal-title":"Pharm World Sci"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0025","doi-asserted-by":"crossref","first-page":"987e93","DOI":"10.1111\/j.1464-5491.2011.03296.x","article-title":"Diabetes medication assistance service stage 1: impact and sustainability of glycaemic and lipids control in patients with type 2 diabetes","volume":"28","author":"Krass","year":"2011","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0030","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s11096-015-0140-1","article-title":"The organizational framework of community pharmacies in Europe","volume":"37","author":"Martins","year":"2015","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.sapharm.2019.02.002","article-title":"A survey to assess the availability, implementation rate and remuneration of pharmacist-led cognitive services in Europe","volume":"16","author":"Soares","year":"2020","journal-title":"Res Social Adm Pharm"},{"issue":"9859","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0040","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0045","unstructured":"Rodrigues AP, Gaio V, Kislaya I, Graff-Iversen S, Cordeiro E, Silva AC, Namorado S, Barreto M, Gil AP, Antunes L, Santos A. Preval\u00eancia de hipertens\u00e3o arterial em Portugal: resultados do Primeiro Inqu\u00e9rito Nacional com Exame F\u00edsico (INSEF 2015). Observa\u00e7\u00f5es_Boletim Epidemiol\u00f3gico. vol. 2nd series, esp. 9, (2015) pp. 11-14."},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0050","series-title":"Pharmacy-based hypertension management model: protocol and guidelines: a joint CINDI\/EuroPharm Forum project","author":"World Health Organization","year":"2005"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0055","series-title":"Guaranteeing continued access to medicines [annual report]. Brussels: s.n.","author":"Pharmaceutical Group of the European Union","year":"2018"},{"issue":"6","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0060","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1331\/108658002762063691","article-title":"Evaluation of a pharmaceutical care program for hypertensive patients in rural Portugal","volume":"42","author":"Gar\u00e7\u00e3o","year":"2002","journal-title":"J Am Pharm Assoc (1996)"},{"issue":"1","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0065","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11096-010-9474-x","article-title":"Pharmacist intervention program to enhance hypertension control: a randomised controlled trial","volume":"33","author":"Morgado","year":"2011","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0070","first-page":"164","article-title":"Clinical impact of a pharmaceutical care programme developed in a family health unit: results of a pharmacist-physician collaboration in the treatment of hypertensive patients","volume":"8","author":"Condinho","year":"2016","journal-title":"Rev Port Farmacoter"},{"issue":"4","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0075","first-page":"782","article-title":"Assessing the effects on clinical outcomes of an outsourced pharmaceutical care service in Portuguese community pharmacies","volume":"34","author":"Atenci\u00f3n Farmac\u00e9utica, Lda","year":"2015","journal-title":"Latin Am J Pharm"},{"issue":"Suppl 1","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0080","article-title":"Effectiveness of a collaborative care intervention between pharmacies and primary care targeting hypertension and hyperlipidemia: a multicentre quasi-experimental controlled trial (USFarm\u00e1cia)","volume":"11","author":"Costa","year":"2019","journal-title":"Revista Portuguesa de Farmacoterapia"},{"issue":"4","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0085","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/0897190016645023","article-title":"Cholesterol point-of-care testing for community pharmacies: a review of the current literature","volume":"30","author":"Haggerty","year":"2017","journal-title":"J Pharm Pract"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0090","unstructured":"Dire\u00e7\u00e3o Geral da Sa\u00fade. Norma n\u00ba 005\/2013 de 19\/03\/2013, atualizada a 21\/01\/2015: Avalia\u00e7\u00e3o do Risco Cardiovascular SCORE [Systematic Coronary Risk Evaluation]. Lisboa\u2009: s.n., 2015. 005\/2013."},{"issue":"5","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10389-008-0183-z","article-title":"Assessment of global cardiovascular risk and risk factors in Portugal according to the SCORE\u00ae model","volume":"16","author":"de Oliveira Martins","year":"2008","journal-title":"J Public Health"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0100","series-title":"Pharmacists' interventions in cardiovascular disease awareness and assessment","author":"Rosa","year":"2017"},{"issue":"5","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0105","first-page":"493","article-title":"Pharmacist interventions in the management of type 2 diabetes mellitus: a systematic review of randomized controlled trials","volume":"22","author":"Pousinho","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0115","article-title":"Diabetes prevalence","author":"OECD\/European Union","year":"2018"},{"issue":"9733","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0120","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0130","series-title":"Diabetes: Factos e N\u00fameros\u2013O Ano de 2015. \u2212 Relat\u00f3rio Anual do Observat\u00f3rio Nacional da Diabetes","author":"Sociedade Portuguesa de Diabetologia","year":"2016"},{"issue":"4","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091157","article-title":"The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting","volume":"9","author":"Willis","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40545-019-0166-1","article-title":"Diabetes policies and pharmacy-based diabetes interventions in Portugal: a comprehensive review. 2019","volume":"12","author":"Costa","year":"2019","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0145","series-title":"World diabetes month campaign in Portuguese pharmacies","year":"2016"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0150","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s11239-019-02000-x","article-title":"Awareness campaigns of atrial fibrillation as an opportunity for early detection by pharmacists- an international cross-sectional study","volume":"49","author":"Costa","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0155","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.sapharm.2019.08.036","article-title":"Raising awareness and early detection of atrial fibrillation, an experience resorting to innovative technology and interprofessional collaboration","volume":"16","author":"Cunha","year":"2020","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0160","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12916-019-1351-4","article-title":"Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study","volume":"17","author":"Banks","year":"2019","journal-title":"BMC Med"},{"issue":"7","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0165","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.2019.10298","article-title":"Association of smoking cessation with subsequent risk of cardiovascular disease","volume":"322","author":"Duncan","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0170","series-title":"Pharmacist-led interventions for tobacco smoking cessation: a review of clinical effectiveness and cost-effectiveness. [Internet]","author":"Brett","year":"2019"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0175","series-title":"Community pharmacy interventions for public health priorities: a systematic review of community pharmacy-delivered smoking, alcohol and weight management interventions","author":"Brown","year":"2016"},{"issue":"1","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0180","first-page":"42","article-title":"Smoking cessation in a community pharmacy: preliminary results of a pharmaceutical care programme","volume":"22","author":"Condinho","year":"2015","journal-title":"Vitae"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0185","series-title":"Physical activity promotion in the Portuguese pharmacies: a survey of knowledge, attitudes and behaviours of pharmacists","author":"Cust\u00f3dio","year":"2019"},{"issue":"3","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0190","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11096-007-9174-3","article-title":"Change of body weight and lifestyle of persons at risk for diabetes after screening and counselling in pharmacies","volume":"30","author":"Botomino","year":"2008","journal-title":"Pharm World Sci"},{"issue":"1","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0195","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/19325037.2003.10603523","article-title":"Educating pharmacy students about nutrition and physical activity counseling","volume":"34","author":"Kotecki","year":"2003","journal-title":"Am J Health Educ"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0200","series-title":"Health at a glance 2019: OECD indicators","author":"OECD","year":"2019"},{"issue":"3","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0210","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s13679-014-0110-2","article-title":"What is the role of the pharmacist in obesity management?","volume":"3","author":"O\u2019Neal","year":"2014","journal-title":"Current Obesity Reports"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0215","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/IPRP.S72206","article-title":"Pharmacist interventions for obesity: improving treatment adherence and patient outcomes","volume":"4","author":"Jordan","year":"2015","journal-title":"Integr Pharm Res Prac"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0220","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1016\/j.clnu.2018.06.1532","article-title":"Dietary intervention for overweight and obese patients followed in Portuguese community pharmacies","volume":"37","author":"Ramos","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0225","series-title":"Screening and brief interventions for alcohol misuse delivered in the community pharmacy setting: a pilot study","author":"Watson","year":"2011"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0230","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/add.12994","article-title":"The effectiveness of brief alcohol interventions delivered by community pharmacists: randomised controlled trial","volume":"110","author":"Dhital","year":"2015","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0235","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13722-018-0130-4","article-title":"Study protocol testing toolkit versus usual care for implementation of screening, brief intervention, referral to treatment in hospitals: a phased cluster randomized approach","volume":"13","author":"Newhouse","year":"2018","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0240","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s11096-010-9393-x","article-title":"Provision of pharmaceutical care by community pharmacists: a comparison across Europe","volume":"32","author":"Hughes","year":"2010","journal-title":"Pharm World Sci"},{"issue":"6","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0245","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/jep.12783","article-title":"Provision of pharmaceutical care by community pharmacists across Europe: is it developing and spreading?","volume":"23","author":"Costa","year":"2017","journal-title":"J Eval Clin Prac"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0250","unstructured":"Minist\u00e9rio da Sa\u00fade. Decreto-Lei n\u00ba 307\/2007. [Di\u00e1rio da Rep\u00fablica] Lisboa: s.n. 2007."},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0255","unstructured":"Minist\u00e9rio da Sa\u00fade. Portaria n.\u00ba 1429\/2007. [Di\u00e1rio da Rep\u00fablica] Lisboa: s.n. 2007."},{"issue":"4","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0260","first-page":"255","article-title":"Implementa\u00e7\u00e3o de Cuidados Farmac\u00eauticos em Portugal, 6 anos depois","volume":"5","author":"Martins","year":"2013","journal-title":"Revista Portuguesa de Farmacoterapia"},{"issue":"8","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0265","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.sapharm.2019.11.002","article-title":"Pharmacist-led medication review procedures: a survey across Europe","volume":"16","author":"Imfeld-Isenegger","year":"2020","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0270","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11096-013-9852-2","article-title":"Assessing the impact of multi-compartment compliance aids on clinical outcomes in the elderly: a pilot study","volume":"36","author":"Mosca","year":"2014","journal-title":"Int J Clin Pharm."},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0275","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1211\/ijpp.13.3.0006","article-title":"Effect or reminder cards on compliance with antihypertensive medication","volume":"3","author":"Costa","year":"2005","journal-title":"Int J Pharm Pract"},{"issue":"2","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0280","first-page":"88","article-title":"How to measure (or not) compliance to eradication therapy?","volume":"4","author":"Martins","year":"2006","journal-title":"Pharm Pract"},{"issue":"4","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0285","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s11096-015-0108-1","article-title":"Primary non-adherence in Portugal: findings and implications","volume":"37","author":"Costa","year":"2015","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0290","first-page":"104","article-title":"Effects of economic recession on elderly patients\u2019 perceptions of access to health care and implications on their medicines-taking behaviour in Portugal, 2013","volume":"39","author":"Costa","year":"2016","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0295","unstructured":"Minist\u00e9rio da Sa\u00fade. Portaria n\u00ba 97\/2018: First modification to the document defining services provided by pharmacies. [Di\u00e1rio da Rep\u00fablica] Lisboa: s.n, 2018."},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0300","series-title":"Therapeutic Notes (TN)\u2014a tool for reinforcing interaction between Portuguese pharmacists and doctors","author":"Miranda","year":"2018"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0305","first-page":"590","article-title":"Community pharmacists\u2019 and physicians\u2019 interprofessional work: insights from qualitative studies with multiple stakeholders","volume":"26","author":"Paulino","year":"2010","journal-title":"Rev Port Clin Geral"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0310","series-title":"The future for health\u2014working group 3: staffing the services. s.l. : Calouste Gulbenkian Foundation","isbn-type":"print","author":"Calouste Gulbenkian Foundation","year":"2015","ISBN":"http:\/\/id.crossref.org\/isbn\/9789898807137"},{"issue":"3","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0315","first-page":"2043","article-title":"Primary health care policy and vision for community pharmacy and pharmacists in Portugal","volume":"18","author":"Ribeiro","year":"2020","journal-title":"Pharm Pract"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0320","article-title":"\u201cEach one has their own role\u201d: Exploratory study on consumers\u2019 perceptions about nutritionists services provided in community pharmacies","author":"Borralho","year":"2020","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/B978-0-12-819378-5.00011-8_bb0325","series-title":"The contribution of community pharmacies to diabetes control: a multidisciplinary approach","author":"Paulino","year":"2017"},{"issue":"Suppl 1","key":"10.1016\/B978-0-12-819378-5.00011-8_bb0330","first-page":"42","article-title":"Servi\u00e7o do P\u00e9 Diab\u00e9tico em farm\u00e1cias comunit\u00e1rias: um contributo multidisciplinar","volume":"12","author":"Pinto","year":"2017","journal-title":"Rev Port Diabetes"}],"container-title":["Pharmacy Practice Research Case Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128193785000118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128193785000118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T23:18:59Z","timestamp":1613949539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128193785000118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128193785"],"references-count":62,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-819378-5.00011-8","relation":{},"subject":[],"published":{"date-parts":[[2021]]}}}